BeStock  
Stocks › Biotechnology › NKTR

Nektar Therapeutics NKTR

US equityMarket cap rank #3135Biotechnology
$30.20 −$2.34 (-7.19%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $30.20 0.00%
Open$31.66
Prev close$32.54
Day range$30.13 – $32.35
Volume1.02M
Market cap$1.03B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-6.0x
CheapRich

Below its usual level · 20th percentile, 5-year average -2.9x

Price / book1.5x
CheapRich

Around its usual level · 43rd percentile, 5-year average 2.3x

#2494 of 5330 stocks by PB (1 = cheapest)

Price / sales24.4x
CheapRich

Near the top of its 5-year range · 86th percentile, 5-year average 10.9x

#4769 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-13x-8x-4x1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$53.82
Price vs. fair value-43.9%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 1.50 – 2.29 43% (cheaper than usual) #2494 of 5330 (1 = cheapest)
PE -6.02 -3.81 -2.93 20% (cheaper than usual) –
PS 24.44 37.37 10.95 86% (pricier than usual) #4769 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on NKTR.

Sign in to join the discussion.

Scroll to Top